ReviewNature medicine2025
The economics of investing in women and health.
Review in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Improving Breast Cancer Outcomes Through Quality Care: Call to Action for the Implementation of the Breast Cancer Care Quality Index (BCCQI).International journal of environmental research and public health · 2026Article
- Aligning femtech innovation With equity: a strategic framework for real world impact.Frontiers in global women's health · 2026Article
- Innovation in women's health must be led by women.BMJ (Clinical research ed.) · 2025Article
- Gender, equity, and resilient primary health care in Latin America and the Caribbean: aligned and synergistic goals.Lancet regional health. Americas · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Investments in women and their health hold transformative potential, serving as powerful drivers of gender equality, poverty reduction, equity and economic development. However, current investments are both insufficient and inappropriately designed to address the complex health needs of women throughout the life course. This paper explores the intrinsic returns that would stem from a virtuous cycle of investment in the health of women-by allowing full access to education and fair labor-force participation-as well as the instrumental returns to economic growth and sustainability. We highlight the vital and dual role of health systems in challenging structural biases affecting women in their consumption of health-care services, as well as appropriately recognizing and compensating women's contributions as health care and care producers. By proactively and deliberately investing in gender equality throughout the life course and addressing the social determinants of women's health, heath systems and governments can support optimal health as well as economic and equity outcomes for all women and for the societies in which they thrive.
Indexed as
Identifiers
40775054What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.